|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/122 | (2006.01) |
| A61P 25/00 | (2006.01) |
| (11) | Number of the document | 2424513 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09795720.3 |
| Date of filing the European patent application | 2009-12-18 | |
| (97) | Date of publication of the European application | 2012-03-07 |
| (45) | Date of publication and mention of the grant of the patent | 2015-05-20 |
| (46) | Date of publication of the claims translation | 2015-08-25 |
| (86) | Number | PCT/EP2009/009148 |
| Date | 2009-12-18 |
| (87) | Number | WO 2010/124713 |
| Date | 2010-11-04 |
| (30) | Number | Date | Country code |
| 09006030 | 2009-04-30 | EP | |
| 174170 P | 2009-04-30 | US |
| (72) |
MEIER, Thomas, CH
BIELEKOVA, Bibiana, US
MCFARLAND, Henry, F., US
|
| (73) |
Santhera Pharmaceuticals (Schweiz) AG,
Hammerstrasse 49, 4410 Liestal,
CH
The United States of America as represented by the Department of Health and Human Services, 200 Independence Avenue, S.W., Washington, DC 20201, US |
| (74) |
Irena Milda SRĖBALIENĖ,
Patentinių paslaugų centras, UAB, J. Basanavičiaus g. 11/1, LT-03108 Vilnius,
LT
|
| (54) | Chinono darinys 2,3-dimetoksi-5-metil-6-(10-hidroksidecil)-1,4-benzochinonas, skirtas pirminės progresuojančios išsėtinės sklerozės gydymui |
| QUINONE DERIVATIVE 2,3-DIMETHOXY-5-METHYL-6-(10-HYDROXYDECYL)-1,4-BENZOQUINONE FOR THE TREATMENT OF PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS |
| Payment date | Validity (years) | Amount | |
| 2017-12-01 | 9 | 208.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2018-12-18 |